Home Your basket
• Orbital Kimura’s disease:...
   Price 14.00 €
• A report of two cases of ...
   Price 5.50 €
• Benign paroxysmal positio...
   Price 10.50 €
• IPSEN Foundation meeting:...
   Price 5.50 €
• Postural control accordin...
   Price 10.50 €
• Side effects and patients...
   Price 10.50 €
• Induction chemotherapy an...
   Price 10.50 €
• Toxic nodular goitre asso...
   Price 5.50 €
• Pseudoaneurysm of the int...
   Price 5.50 €
• Failure rate and revision...
   Price 10.50 €
• Cephalic vein access for ...
   Price 10.50 €
• Bilateral facial nerve pa...
   Price 5.50 €
• Facial threads for face l...
   Price 10.50 €
• Immunohistochemistry expr...
   Price 10.50 €
• Orbital apex syndrome fol...
   Price 10.50 €
• Plastic surgery indicatio...
   Price 10.50 €
• Endoscopic anatomy of the...
   Price 10.50 €
• Cowden syndrome: Otolaryn...
   Price 12.00 €
• Bilateral facial nerve sc...
   Price 10.50 €
• Social consequence of a d...
   Price 10.50 €
• Voice after supracricoid ...
   Price 10.50 €
• Merkel cell carcinoma of ...
   Price 8.50 €
• Adenocarcinoma of the end...
   Price 8.50 €
• Nasal polyposis and olfac...
   Price 10.50 €
• The prevention of voice d...
   Price 10.50 €
• Study on the modeling of ...
   Price 10.50 €
• Zenker's diverticulum: Te...
   Price 10.50 €
• Validity of cervical ausc...
   Price 12.00 €
• Unilateral frontal sinus ...
   Price 8.50 €
• Vocal and behavioral adap...
   Price 10.50 €
• Reconstruction of bone de...
   Price 10.50 €
• Major orbital complicatio...
   Price 8.50 €
• The place of the myocutan...
   Price 10.50 €
• Metastatic angiosarcoma t...
   Price 5.50 €
• Aesthetic parotidectomy: ...
   Price 8.50 €
• Focus on the BPPV: Semont...
   Price 12.50 €

Total Order 346.50 €

contents
2019
   N# 1 |
2018
   N# 1 | 2 | 3 | 4 | 5 |
2017
   N# 1 | 2 | 3 | 4 | 5 |
2016
   N# 1 | 2 | 3 | 4 | 5 |
2015
   N# 1 | 2 | 3 | 4 | 5 |
2014
   N# 1 | 2 | 3 | 4 | 5 |
2013
   N# 1 | 2 | 3 | 4 | 5 |
2012
   N# 1 | 2 | 3 | 4 | 5 |
2011
   N# 1 | 2 | 3 | 4 | 5 |
2010
   N# 1 | 2 | 3 | 4 | 5 |
2009
   N# 1 | 2 | 3 | 4 | 5 |
2008
   N# 1 | 2 | 3 | 4 | 5 |
2007
   N# 1 | 2 | 3 | 4 | 5 |
2006
   N# 1 | 2 | 3 | 4 | 5 |
2005
   N# | 1 | 2 | 3 | 4 | 5 |
2004
   N# 1 | 2 | 3 | 4 | 5 |
2003
   N# 1 | 2 | 3 | 4 | 5 |
2002
   N# 1 | 2 | 3 | 4 | 5 |
2001
   N# 1 | 2 | 3 | 4 | 5 |
2000
   N# | 1 | 2 | 3 | 4 | 5 |
1999
   N# 1 | 2 | 3 | 4 | 5 |
1998
   N# 1 | 2 | 3 | 5 |
1997
   N# 1 | 2 | 3 | 4 | 5 |
1996
   N# 4 | 5 |

Click on the number of the review to see the content
Teaching bulletin CME
List of all teaching bulletins CME.
Editor reading committee
Editor reading committee.
To publish...
Instructions for authors
Archives Press and Books
Select of books and press articles.
Mailing list
News information letter.
Subscription prices


If you wish to adjust the size of the displayed characters, click in the high menu on "Your account" and choose the desired size.



  Contents > Previous page > Article detail print Order
o Issue N# 3 - 2014 o

RHINOLOGY

Polypose nasosinusienne associée à un déficit en sous-classes d'Immunoglobuline G : place de la substi­tu­tion en immunoglobulines polyvalentes


Authors : Nhung Tran Khai Hoan, Karmochkine M, Laccourreye O, Bonfils P. (Paris)

Ref. : Rev Laryngol Otol Rhinol. 2014;135,3:151-155.

Article published in french
Downloadable PDF document french



Summary : Purpose: To study the effect of the introduction of a substi­t­u­t­ion by intravenous Immunoglobulins (Ig IV) at patients with immunoglobulins G (IgG) subclasses deficiency and nasal polyposis. Material and methods: Prospective study concer­ning five patients with IgG subclasses deficiency and nasal polyposis treated by Ig IV. Rhinologic, otologic and pulmonary symptoms, exacerbations of nasal polyposis, chronic otitis and asthma as well as the number of antibiotics and corticoids treat­ments were counted during the Ig IV substitution. Objectives: To study the association between IgIV substitution and the number of exacerbations of nasal polyposis, chronic otitis, asthma and the number of antibiotics and corticoids treatments in patients with IgG subclasses deficiency and nasal polyposis. Results: Five patients with a IgG subclass deficiency and nasal polyposis were substituted. The number of antibiotics and corticoids cures increased at one patient and remained stable at four others. The number of sinus, ear and lung infec­tions as well as the global rhinologic score of symptoms and the endoscopic stage of the nasal polyposis remained stable. In the absence of efficiency of the treatment, this one was interrupted at the end of 6 months for patients n° 1 and n° 3, 24 months for patient n° 4 and 42 months for patient n° 5. Conclusion: The current study failed to highlight clinical improvement in patients wih IgG subclasses deficiency and nasal polyposis treated by Ig IV. A previous study had not allowed to find a link between IgG subclasses deficiency and severity of nasal polyposis, what seems to be confirmed by the absence of improvement brought during the substitution of this deficit in the current study.

Price : 15.00 €      order
|


Subscribe online - Pay by credit card!


© Copyright 1999-2024 - Revue de Laryngologie   Réalisation - Hébergement ELIDEE